Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease — Stella

Home/Mild Cognitive Impairment/TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

View on ClinicalTrials.gov

Recruiting

Back to Mild Cognitive Impairment trials

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Shiley Marcos Alzheimer's Disease Center, San Diego, California

Key details

Phase

Early testing

Sponsor

University of California, San Diego

Collaborators

National Institute on Aging (NIA)

Enrollment target

~60 participants

Started

April 2025

Primary completion

December 2026

Age range

60 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.